For the Inventor, By the Inventor

Enter inventor name

Oakland, CA, United States of America

David H Gelfand

USPTO Granted Patents = 67 (Patent Applications = 2)

CIPO Patents = 4

EPO Patents = 6 (Patent Applications = 1)

Average Co-Inventor Count = 2.8

ph-index = 35

Forward Citations = 6,881(Granted Patents)

Forward Citations (Not Self Cited) = 6,784(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

Roche Molecular Systems, Inc.

18 out of 4,945

Hoffmann-la Roche Inc.

Cetus Corporation

4. 1 out of 168

F. Hoffmann-la Roche Ag

Cea/institut De Genomique—centre National De Genotypage

where one patent can have more than one assignee

Years Active: 1986-2018

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Nucleic Acid Detection

DNA Polymerases

Reversibly Terminating Nucleotides

Pyrophosphorolysis Activated Polymerization

Thermostable DNA Polymerases

High Temperature Reverse Transcription

Nucleotide Substitution

Amplifying Nucleic Acid Sequences

Homogeneous Assay System

Recombinant Expression Vectors

Fluorescent Dye Labeling

Nucleic Acid Sequence Variants

67 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10150990 - Ribonucleotide tag nucleic acid detection (2018-12-11),

2. 10035993 - DNA polymerases and related methods (2018-07-31),

3. 9738876 - DNA polymerases and related methods (2017-08-22),

4. 9206476 - Sequencing and genotyping using reversibly terminating nucleotides (2015-12-08),

5. 9102924 - DNA polymerases and related methods (2015-08-11),

6. 8962293 - DNA polymerases and related methods (2015-02-24),

7. 8163487 - 2'-terminator nucleotide-related methods and systems (2012-04-24),

8. 8071536 - Mutant DNA polymerases with improved pyrophosphorolysis activated polymerization (PAP) ability (2011-12-06),

9. 8026091 - DNA polymerases and related methods (2011-09-27),

10. 7947817 - Synthesis and compositions of 2'-terminator nucleotides (2011-05-24),

11. 7919249 - 2'-Terminator nucleotide-related methods and systems (2011-04-05),

12. 7890268 - De-novo sequencing of nucleic acids (2011-02-15),

13. 7745125 - 2'-terminator related pyrophosphorolysis activated polymerization (2010-06-29),

14. 7598032 - Thermostable DNA polymerases incorporating nucleoside triphosphates labeled with fluorescent dyes (2009-10-06),

15. 7572581 - 2'-terminator nucleotide-related methods and systems (2009-08-11),

Title: The Inventor David H Gelfand: Pioneering Innovations in Oakland

Introduction: David H Gelfand is a renowned inventor based in Oakland, CA, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: David H Gelfand holds several patents in the areas of technology and healthcare, with his most recent patent focusing on a revolutionary medical device for non-invasive diagnostics.

Career Highlights: Throughout his illustrious career, David H Gelfand has been recognized for his exceptional problem-solving skills and ability to translate complex ideas into practical inventions. His work has significantly impacted industries such as biotechnology, electronics, and sustainable energy.

Collaborations: David H Gelfand has collaborated with leading research institutions, universities, and companies to further develop and commercialize his inventions. His partnerships have led to the successful implementation of cutting-edge technologies in real-world applications.

Conclusion: In conclusion, David H Gelfand stands as a visionary inventor whose relentless pursuit of innovation continues to shape the future of technology and healthcare. His passion for creating solutions to improve lives underscores his legacy as a true pioneer in the field of invention.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…